MDPI and ACS Style
Lassiter, G.; Melancon, C.; Rooney, T.; Murat, A.-M.; Kaye, J.S.; Kaye, A.M.; Kaye, R.J.; Cornett, E.M.; Kaye, A.D.; Shah, R.J.;
et al. Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Neurol. Int. 2020, 12, 89-108.
https://doi.org/10.3390/neurolint12030016
AMA Style
Lassiter G, Melancon C, Rooney T, Murat A-M, Kaye JS, Kaye AM, Kaye RJ, Cornett EM, Kaye AD, Shah RJ,
et al. Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects. Neurology International. 2020; 12(3):89-108.
https://doi.org/10.3390/neurolint12030016
Chicago/Turabian Style
Lassiter, Grace, Carlie Melancon, Tyler Rooney, Anne-Marie Murat, Jessica S. Kaye, Adam M. Kaye, Rachel J. Kaye, Elyse M. Cornett, Alan D. Kaye, Rutvij J. Shah,
and et al. 2020. "Ozanimod to Treat Relapsing Forms of Multiple Sclerosis: A Comprehensive Review of Disease, Drug Efficacy and Side Effects" Neurology International 12, no. 3: 89-108.
https://doi.org/10.3390/neurolint12030016